WO2009004058A3 - Novel prolactin compounds - Google Patents

Novel prolactin compounds Download PDF

Info

Publication number
WO2009004058A3
WO2009004058A3 PCT/EP2008/058593 EP2008058593W WO2009004058A3 WO 2009004058 A3 WO2009004058 A3 WO 2009004058A3 EP 2008058593 W EP2008058593 W EP 2008058593W WO 2009004058 A3 WO2009004058 A3 WO 2009004058A3
Authority
WO
WIPO (PCT)
Prior art keywords
compounds
prolactin
novel
novel prolactin
analogues
Prior art date
Application number
PCT/EP2008/058593
Other languages
French (fr)
Other versions
WO2009004058A2 (en
Inventor
Jens Breinholt
Per Franklin Nielsen
Leif Christensen
Leif Noerskov-Lauritsen
Anders Svensson
Original Assignee
Novo Nordisk As
Jens Breinholt
Per Franklin Nielsen
Leif Christensen
Leif Noerskov-Lauritsen
Anders Svensson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2007/007863 external-priority patent/WO2008028684A2/en
Application filed by Novo Nordisk As, Jens Breinholt, Per Franklin Nielsen, Leif Christensen, Leif Noerskov-Lauritsen, Anders Svensson filed Critical Novo Nordisk As
Priority to EP08802942A priority Critical patent/EP2167059A2/en
Priority to US12/666,395 priority patent/US20100292444A1/en
Publication of WO2009004058A2 publication Critical patent/WO2009004058A2/en
Publication of WO2009004058A3 publication Critical patent/WO2009004058A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/57554Prolactin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Ink Jet (AREA)
  • Detergent Compositions (AREA)

Abstract

The present invention relates to prolactin analogues, which analogues have increased resistance to deamidation.
PCT/EP2008/058593 2007-07-05 2008-07-03 Novel prolactin compounds WO2009004058A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP08802942A EP2167059A2 (en) 2007-07-05 2008-07-03 Novel prolactin compounds
US12/666,395 US20100292444A1 (en) 2007-07-05 2008-07-03 Novel Prolactin Compounds

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
EP07111799 2007-07-05
EP07111799.8 2007-07-05
EPPCT/EP2007/007863 2007-09-10
PCT/EP2007/007863 WO2008028684A2 (en) 2006-09-08 2007-09-10 Peptides with high affinity for the prolactin receptor
EP08388007.0 2008-02-09
EP08388007 2008-02-09
EP08101470.6 2008-02-11
EP08101470 2008-02-11
EP08101589.3 2008-02-13
EP08101589 2008-02-13

Publications (2)

Publication Number Publication Date
WO2009004058A2 WO2009004058A2 (en) 2009-01-08
WO2009004058A3 true WO2009004058A3 (en) 2009-03-12

Family

ID=39971060

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/058593 WO2009004058A2 (en) 2007-07-05 2008-07-03 Novel prolactin compounds

Country Status (2)

Country Link
EP (1) EP2167059A2 (en)
WO (1) WO2009004058A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1464702A1 (en) * 2001-12-28 2004-10-06 Chugai Seiyaku Kabushiki Kaisha Method of stabilizing protein
US20050250689A1 (en) * 2002-12-13 2005-11-10 Brooks Charles L Antagonists for human prolactin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1464702A1 (en) * 2001-12-28 2004-10-06 Chugai Seiyaku Kabushiki Kaisha Method of stabilizing protein
US20050250689A1 (en) * 2002-12-13 2005-11-10 Brooks Charles L Antagonists for human prolactin

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
HARO L S ET AL: "Secreted mouse prolactin (PRL) and stored ovine PRL. II. Role of amides in receptor binding and immunoreactivity.", ENDOCRINOLOGY JAN 1985, vol. 116, no. 1, January 1985 (1985-01-01), pages 353 - 358, XP009109049, ISSN: 0013-7227 *
LEWIS U J ET AL: "Kinetic study of the deamidation of growth hormone and prolactin", BBA - PROTEIN STRUCTURE, ELSEVIER SCIENCE BV, AMSTERDAM, NL, vol. 214, no. 3, 29 September 1970 (1970-09-29), pages 498 - 508, XP023386313, ISSN: 0005-2795, [retrieved on 19700929] *
ROBINSON N E ET AL: "Structure-dependent nonenzymatic deamidation of glutaminyl and asparaginyl pentapeptides", JOURNAL OF PEPTIDE RESEARCH, vol. 63, no. 5, May 2004 (2004-05-01), pages 426 - 436, XP002504994, ISSN: 1397-002X *
See also references of EP2167059A2 *
SINHA Y N: "Structural variants of prolactin: occurrence and physiological significance.", ENDOCRINE REVIEWS JUN 1995, vol. 16, no. 3, June 1995 (1995-06-01), pages 354 - 369, XP009108998, ISSN: 0163-769X *

Also Published As

Publication number Publication date
EP2167059A2 (en) 2010-03-31
WO2009004058A2 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
WO2010077740A3 (en) Novel antiviral compounds, compositions, and methods of use
EG25365A (en) Pesticidal compositions.
AP2010005465A0 (en) Pesticidal compositions.
WO2013023732A3 (en) Ternesite used as an activator for latent-hydraulic and pozzolanic materials
IL220281A (en) Compounds which molecule comprises dihydroazolyl and bicyclic aromatic n-containing rings, as well as pesticidal compositions comprising the same
EP2382230B8 (en) Peptides kxk, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
ZA200806350B (en) Stable, concentrated herbicidal compositions
WO2010020599A3 (en) Thickening glyphosate formulations
WO2012061290A3 (en) Pesticidal compositions and processes related thereto
WO2009043889A3 (en) Oxadiazole derivatives
EP2361902A4 (en) 4,6-diaminonicotinamide compound
WO2012042371A3 (en) Pharmaceutical composition
WO2009129246A3 (en) Compositions and methods for preparing and using same
WO2011051199A3 (en) Aqueous formulations based on crystalline or semicrystalline polyurethane polymers
AP2281A (en) Novel compounds.
WO2009037061A3 (en) Use of hydrophobin polypeptides as penetration enhancers
CA2830549C (en) Methods and compositions for preparing noribogaine from voacangine
WO2008080772A3 (en) Low residue antiperspirant stick
WO2009130479A3 (en) Virus
EP2282735A4 (en) Compounds, compositions and methods for making the same
WO2009071460A3 (en) New non-selective somatostatin analogues
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
WO2009053877A3 (en) Fabric softening compositions having improved stability upon storage
WO2007095630A3 (en) New ubiquinone analogs and methods of use
WO2009052221A3 (en) Methods for extracting platelets and compositions obtained therefrom

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08802942

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2008802942

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 12666395

Country of ref document: US